Why Is Immuneering Corp (IMRX) Stock Surpassing 65.57% from Its 50-Day SMA?

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also reduced Hold rating with a price target of $3. Additionally, Needham initiated Buy rating on December […]

Immuneering Corp (IMRX) Stock Rated Buy by Needham

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also reduced Hold rating with a price target of $3. Additionally, Needham initiated Buy rating on December […]

Immuneering Corp (IMRX) Stock: Greater Than Its Current Valuation?

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also reduced Hold rating with a price target of $3. Additionally, Needham initiated Buy rating on December […]

Immuneering Corp (IMRX) Stock: Unveiling Its Hidden Strengths

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also reduced Hold rating with a price target of $3. Additionally, Needham initiated Buy rating on December […]

Needham Issues Buy Rating for Immuneering Corp (IMRX) Stock

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also reduced Hold rating with a price target of $3. Additionally, Needham initiated Buy rating on December […]

Immuneering Corp (IMRX) Stock: Analyzing Its Quiet Power

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy, as announced on March 15, 2024 according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also downgraded from Buy to Hold rating with a price target range from $3 to $16 . Additionally, […]

Immuneering Corp (IMRX) Stock: Analyzing Its Quiet Power

Needham has recently reiterated Immuneering Corp (IMRX) stock to Buy, as announced on March 15, 2024 according to Finviz. Earlier, on March 15, 2024, TD Cowen had reduced the stock from a Outperform to Market Perform. Jefferies also downgraded from Buy to Hold rating with a price target range from $3 to $16. Additionally, Needham […]

It is likely that Immuneering Corp (IMRX) Stock will grow up

Needham lowered the price target for the Immuneering Corp (NASDAQ:IMRX) stock to “a Buy”. The rating was released on March 15, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $3. The stock was initiated by Needham, who disclosed in a […]